XML 21 R11.htm IDEA: XBRL DOCUMENT v3.5.0.2
Earnings (Loss) Per Share
9 Months Ended
Sep. 30, 2016
Earnings Per Share [Abstract]  
Earnings (Loss) Per Share

5. Earnings (Loss) Per Share

Basic earnings (loss) per share is computed by dividing net income (loss) by the weighted-average shares of common stock outstanding. For purposes of calculating diluted earnings (loss) per share, the denominator includes both the weighted average shares of common stock outstanding and dilutive common stock equivalents. Dilutive common stock equivalents consist of stock options, restricted stock unit awards and warrants calculated under the treasury stock method.

The calculations of earnings (loss) per share are as follows:

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(In thousands, except per share amounts)

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Basic Loss per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

157

 

 

$

(5,133

)

 

$

148

 

 

$

(18,433

)

Less: Net income attributable to non-controlling interest

 

$

(151

)

 

$

(111

)

 

$

(142

)

 

$

(120

)

Less: Accretion of redemption preference on redeemable

   convertible non-controlling interest

 

$

(10,191

)

 

$

0

 

 

$

(18,344

)

 

$

0

 

Net loss attributable to Allscripts Healthcare Solutions, Inc.

   stockholders

 

$

(10,185

)

 

$

(5,244

)

 

$

(18,338

)

 

$

(18,553

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

186,226

 

 

 

188,944

 

 

 

187,190

 

 

 

183,725

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic Loss per Common Share

 

$

(0.06

)

 

$

(0.03

)

 

$

(0.10

)

 

$

(0.10

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Loss per Common Share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Net income (loss)

 

$

157

 

 

$

(5,133

)

 

$

148

 

 

$

(18,433

)

Less: Net income attributable to non-controlling interest

 

$

(151

)

 

$

(111

)

 

$

(142

)

 

$

(120

)

Less: Accretion of redemption preference on redeemable

   convertible non-controlling interest

 

$

(10,191

)

 

$

0

 

 

$

(18,344

)

 

$

0

 

Net loss attributable to Allscripts Healthcare Solutions, Inc.

   stockholders

 

$

(10,185

)

 

$

(5,244

)

 

$

(18,338

)

 

$

(18,553

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average common shares outstanding

 

 

186,226

 

 

 

188,944

 

 

 

187,190

 

 

 

183,725

 

Dilutive effect of stock options, restricted stock unit awards

   and warrants

 

 

0

 

 

 

0

 

 

 

0

 

 

 

0

 

Weighted-average common shares outstanding assuming

   dilution

 

 

186,226

 

 

 

188,944

 

 

 

187,190

 

 

 

183,725

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted Loss per Common Share

 

$

(0.06

)

 

$

(0.03

)

 

$

(0.10

)

 

$

(0.10

)

As a result of the net loss attributable to Allscripts Healthcare Solutions, Inc. stockholders for the three and nine months ended September 30, 2016 and 2015, we used basic weighted-average common shares outstanding in the calculation of diluted loss per share for that period, since the inclusion of any stock equivalents would be anti-dilutive.

The following stock options, restricted stock unit awards and warrants are not included in the computation of diluted earnings (loss) per share as the effect of including such stock options, restricted stock unit awards and warrants in the computation would be anti-dilutive:

 

 

Three Months Ended

September 30,

 

 

Nine Months Ended

September 30,

 

(In thousands)

 

2016

 

 

2015

 

 

2016

 

 

2015

 

Shares subject to anti-dilutive stock options, restricted stock

   unit awards and warrants excluded from calculation

 

 

27,580

 

 

 

23,562

 

 

 

26,219

 

 

 

25,359